Release Date: January 16, 2026
Expiration Date: February 16, 2026
Activity Overview
This educational activity is an archive of the live presentation held on January 9, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational program is directed toward medical oncologists, pathologists, surgical oncologists, and other physicians involved in the management of GI cancers.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Analyze the latest evidence for currently available treatments used in the management of gastric, GEJ, and esophageal adenocarcinomas (GEAs)
- Evaluate emerging clinical trial data for targeted treatment strategies across GEAs
- Select appropriate treatment for patients with GEA based on tumor biomarkers and other individual patient, disease, and treatment considerations
- Implement strategies to mitigate and manage the AEs associated with targeted therapy for GEA

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here